Oral post-lesion administration of 5-HT(1A) receptor agonist repinotan hydrochloride (BAY x 3702) attenuates NMDA-induced delayed neuronal death in rat magnocellular nucleus basalis.
about
Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspirone5-HT(1A) receptor function in major depressive disorderA delayed and chronic treatment regimen with the 5-HT1A receptor agonist 8-OH-DPAT after cortical impact injury facilitates motor recovery and acquisition of spatial learningA combined therapeutic regimen of buspirone and environmental enrichment is more efficacious than either alone in enhancing spatial learning in brain-injured pediatric ratsNeither in vivo MRI nor behavioural assessment indicate therapeutic efficacy for a novel 5HT(1A) agonist in rat models of ischaemic stroke.Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury.Evaluation of a combined therapeutic regimen of 8-OH-DPAT and environmental enrichment after experimental traumatic brain injury.Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions?Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in MiceThe role of serotonin in memory: interactions with neurotransmitters and downstream signaling.5-hydroxytryptamine1A (5-HT1A) receptor agonists: A decade of empirical evidence supports their use as an efficacious therapeutic strategy for brain trauma.Yokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert.Rabbit forebrain cholinergic system: morphological characterization of nuclei and distribution of cholinergic terminals in the cerebral cortex and hippocampus.
P2860
Q24633449-2C34B58F-5054-4816-8F2E-900E2E51136DQ24643511-BB892B8F-DBDA-4AC8-9E1F-880DBB1251E9Q24651403-9DA21276-1BA8-4B42-AF5E-CFE5F808CD44Q28397908-97F76DB5-D900-488A-B172-BFF5EF5937FCQ30870744-09675E50-F3BF-43F6-B38D-C977DE0DFF43Q33984607-8B3B6749-E5E8-4578-9F2D-7B8AFEA2C0A6Q34296853-C3EF6CFB-D147-44CF-B451-6547A37940F4Q34771671-0E79F13E-03F1-4B9B-B82D-8353050F57A2Q37053799-265F4653-0444-4D42-B070-7F02073F6B29Q38178842-044A60B6-4A99-4DA2-B226-64087185E1CCQ38650071-0DD9DB46-833C-40C2-843E-EEE275B20455Q41790670-A7DB414C-242D-44B5-9402-276EB8307253Q42440437-DB79E3EE-0B51-4283-846F-205788A2D708
P2860
Oral post-lesion administration of 5-HT(1A) receptor agonist repinotan hydrochloride (BAY x 3702) attenuates NMDA-induced delayed neuronal death in rat magnocellular nucleus basalis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Oral post-lesion administration of 5-HT
@nl
Oral post-lesion administratio ...... magnocellular nucleus basalis.
@en
type
label
Oral post-lesion administration of 5-HT
@nl
Oral post-lesion administratio ...... magnocellular nucleus basalis.
@en
prefLabel
Oral post-lesion administration of 5-HT
@nl
Oral post-lesion administratio ...... magnocellular nucleus basalis.
@en
P2093
P1433
P1476
Oral post-lesion administratio ...... magnocellular nucleus basalis.
@en
P2093
Horvath KM
van der Meeberg EK
P304
P356
10.1016/S0306-4522(01)00444-4
P407
P50
P577
2001-01-01T00:00:00Z